These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24691612)

  • 21. Academic medical centers and conflicts of interest.
    Poses RM; Silverstein S; Smith WR
    JAMA; 2006 Jun; 295(24):2846-7; author reply 2848-9. PubMed ID: 16804145
    [No Abstract]   [Full Text] [Related]  

  • 22. Conflict questions. Insurance execs on healthcare boards prompts worry.
    Benko LB
    Mod Healthc; 2005 May; 35(22):10. PubMed ID: 15940804
    [No Abstract]   [Full Text] [Related]  

  • 23. Academic medical centers and conflicts of interest.
    Meador KJ
    JAMA; 2006 Jun; 295(24):2845; author reply 2848-9. PubMed ID: 16804144
    [No Abstract]   [Full Text] [Related]  

  • 24. Philanthropy, ethics, and leadership in academic psychiatry.
    Roberts LW; Coverdale J; Louie AK
    Acad Psychiatry; 2006; 30(4):269-72. PubMed ID: 16908601
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest.
    Pizzo PA; Lawley TJ; Rubenstein AH
    JAMA; 2017 May; 317(17):1729-1730. PubMed ID: 28464157
    [No Abstract]   [Full Text] [Related]  

  • 26. Academic medical centers and conflicts of interest.
    Goldblum OM; Franzblau MJ
    JAMA; 2006 Jun; 295(24):2845-6; author reply 2848-9. PubMed ID: 16804142
    [No Abstract]   [Full Text] [Related]  

  • 27. Academic medical centers and conflicts of interest.
    Watson PY; Musial JL; Khandewal AK; Buckley JD
    JAMA; 2006 Jun; 295(24):2847-8; author reply 2848-9. PubMed ID: 16804147
    [No Abstract]   [Full Text] [Related]  

  • 28. Insurer joins hospital board . . . expert questions wisdom of Beth Israel appointment.
    Vesely R
    Mod Healthc; 2007 Dec; 37(50):14. PubMed ID: 18203369
    [No Abstract]   [Full Text] [Related]  

  • 29. Why academic medical centers should ban drug company gifts to individuals.
    Strong C
    Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
    [No Abstract]   [Full Text] [Related]  

  • 30. Compensating nonprofit corporate directors: tackling the legal issues.
    Peregrine MW; DeJong RE
    Healthc Leadersh Manag Rep; 2000 Oct; 8(10):1-6. PubMed ID: 11150140
    [No Abstract]   [Full Text] [Related]  

  • 31. Academic medical centers and conflicts of interest.
    Ting JY
    JAMA; 2006 Jun; 295(24):2846; author reply 2848-9. PubMed ID: 16804146
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug reps and the academic medical center: a case for management rather than prohibition.
    Huddle TS
    Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boardroom disclosure. In light of recent corporate scandals, AHA board execs debate whether they should serve on the boards of for-profit companies.
    Galloro V
    Mod Healthc; 2002 Dec; 32(48):8-9, 12-4, 3. PubMed ID: 12510626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 35. How to restore the fiduciary relationship. An interview with Eliot Spitzer. Interview by Louise O'Brien.
    Spitzer E
    Harv Bus Rev; 2004 May; 82(5):70-7, 150. PubMed ID: 15146737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 37. Capitalize on expertise. Three for-profits tap healthcare executives for boards.
    Becker C
    Mod Healthc; 2006 Feb; 36(8):14. PubMed ID: 16515219
    [No Abstract]   [Full Text] [Related]  

  • 38. Using your Web site as an accountability tool.
    Peregrine MW; Schwartz JR
    Trustee; 2004 May; 57(5):24-5. PubMed ID: 15181772
    [No Abstract]   [Full Text] [Related]  

  • 39. Contact with pharmaceutical representatives: where does prudence lead?
    Appelbaum PS
    Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
    [No Abstract]   [Full Text] [Related]  

  • 40. Double dipping, no ethics. Executives and their associations caught up in same pattern of conflicts.
    Burda D
    Mod Healthc; 2006 Feb; 36(6):23. PubMed ID: 16515087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.